"Serious adverse event" in AstraZeneca's COVID-19 vaccine trial revealed as spinal inflammation disorder caused by toxic adjuvants

(Natural News) It has finally been revealed that the participant in AstraZeneca’s Wuhan coronavirus (COVID-19) vaccine trial who suffered a “serious adverse event,” causing a global shutdown of the company’s entire phase-three trial, developed a spinal inflammatory disorder known as transverse myelitis. Company CEO Pascal Soriot told JP Morgan and other investors over a conference...